Antimicrobial resistance in low-resource settings will be exacerbated by counterfeit and substandard drugs.
open
Global / Unspecified, Global
WS02060
Poor-quality medicines accelerate resistance and treatment failure. Track-and-trace systems and quality-testing infrastructure are needed.